
The global Whole Genome Sequencers market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Whole Genome Sequencers Industry Forecast” looks at past sales and reviews total world Whole Genome Sequencers sales in 2023, providing a comprehensive analysis by region and market sector of projected Whole Genome Sequencers sales for 2024 through 2030. With Whole Genome Sequencers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Whole Genome Sequencers industry.
This Insight Report provides a comprehensive analysis of the global Whole Genome Sequencers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Whole Genome Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Whole Genome Sequencers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Whole Genome Sequencers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Whole Genome Sequencers.
United States market for Whole Genome Sequencers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Whole Genome Sequencers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Whole Genome Sequencers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Whole Genome Sequencers players cover Pacific Biosciences, Element Biosciences, Thermo Fisher Scientific, Illumina, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Whole Genome Sequencers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
High Depth Whole Genome Sequencing
Low Depth Whole Genome Sequencing
Segmentation by Application:
Scientific Research
Clinical Medicine
Agriculture
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pacific Biosciences
Element Biosciences
Thermo Fisher Scientific
Illumina
Roche
GeneMind
Mgi Tech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Whole Genome Sequencers market?
What factors are driving Whole Genome Sequencers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Whole Genome Sequencers market opportunities vary by end market size?
How does Whole Genome Sequencers break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Whole Genome Sequencers Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Whole Genome Sequencers by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Whole Genome Sequencers by Country/Region, 2019, 2023 & 2030
2.2 Whole Genome Sequencers Segment by Type
2.2.1 High Depth Whole Genome Sequencing
2.2.2 Low Depth Whole Genome Sequencing
2.3 Whole Genome Sequencers Sales by Type
2.3.1 Global Whole Genome Sequencers Sales Market Share by Type (2019-2024)
2.3.2 Global Whole Genome Sequencers Revenue and Market Share by Type (2019-2024)
2.3.3 Global Whole Genome Sequencers Sale Price by Type (2019-2024)
2.4 Whole Genome Sequencers Segment by Application
2.4.1 Scientific Research
2.4.2 Clinical Medicine
2.4.3 Agriculture
2.4.4 Others
2.5 Whole Genome Sequencers Sales by Application
2.5.1 Global Whole Genome Sequencers Sale Market Share by Application (2019-2024)
2.5.2 Global Whole Genome Sequencers Revenue and Market Share by Application (2019-2024)
2.5.3 Global Whole Genome Sequencers Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Whole Genome Sequencers Breakdown Data by Company
3.1.1 Global Whole Genome Sequencers Annual Sales by Company (2019-2024)
3.1.2 Global Whole Genome Sequencers Sales Market Share by Company (2019-2024)
3.2 Global Whole Genome Sequencers Annual Revenue by Company (2019-2024)
3.2.1 Global Whole Genome Sequencers Revenue by Company (2019-2024)
3.2.2 Global Whole Genome Sequencers Revenue Market Share by Company (2019-2024)
3.3 Global Whole Genome Sequencers Sale Price by Company
3.4 Key Manufacturers Whole Genome Sequencers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Whole Genome Sequencers Product Location Distribution
3.4.2 Players Whole Genome Sequencers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Whole Genome Sequencers by Geographic Region
4.1 World Historic Whole Genome Sequencers Market Size by Geographic Region (2019-2024)
4.1.1 Global Whole Genome Sequencers Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Whole Genome Sequencers Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Whole Genome Sequencers Market Size by Country/Region (2019-2024)
4.2.1 Global Whole Genome Sequencers Annual Sales by Country/Region (2019-2024)
4.2.2 Global Whole Genome Sequencers Annual Revenue by Country/Region (2019-2024)
4.3 Americas Whole Genome Sequencers Sales Growth
4.4 APAC Whole Genome Sequencers Sales Growth
4.5 Europe Whole Genome Sequencers Sales Growth
4.6 Middle East & Africa Whole Genome Sequencers Sales Growth
5 Americas
5.1 Americas Whole Genome Sequencers Sales by Country
5.1.1 Americas Whole Genome Sequencers Sales by Country (2019-2024)
5.1.2 Americas Whole Genome Sequencers Revenue by Country (2019-2024)
5.2 Americas Whole Genome Sequencers Sales by Type (2019-2024)
5.3 Americas Whole Genome Sequencers Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Whole Genome Sequencers Sales by Region
6.1.1 APAC Whole Genome Sequencers Sales by Region (2019-2024)
6.1.2 APAC Whole Genome Sequencers Revenue by Region (2019-2024)
6.2 APAC Whole Genome Sequencers Sales by Type (2019-2024)
6.3 APAC Whole Genome Sequencers Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Whole Genome Sequencers by Country
7.1.1 Europe Whole Genome Sequencers Sales by Country (2019-2024)
7.1.2 Europe Whole Genome Sequencers Revenue by Country (2019-2024)
7.2 Europe Whole Genome Sequencers Sales by Type (2019-2024)
7.3 Europe Whole Genome Sequencers Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Whole Genome Sequencers by Country
8.1.1 Middle East & Africa Whole Genome Sequencers Sales by Country (2019-2024)
8.1.2 Middle East & Africa Whole Genome Sequencers Revenue by Country (2019-2024)
8.2 Middle East & Africa Whole Genome Sequencers Sales by Type (2019-2024)
8.3 Middle East & Africa Whole Genome Sequencers Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Whole Genome Sequencers
10.3 Manufacturing Process Analysis of Whole Genome Sequencers
10.4 Industry Chain Structure of Whole Genome Sequencers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Whole Genome Sequencers Distributors
11.3 Whole Genome Sequencers Customer
12 World Forecast Review for Whole Genome Sequencers by Geographic Region
12.1 Global Whole Genome Sequencers Market Size Forecast by Region
12.1.1 Global Whole Genome Sequencers Forecast by Region (2025-2030)
12.1.2 Global Whole Genome Sequencers Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Whole Genome Sequencers Forecast by Type (2025-2030)
12.7 Global Whole Genome Sequencers Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Pacific Biosciences
13.1.1 Pacific Biosciences Company Information
13.1.2 Pacific Biosciences Whole Genome Sequencers Product Portfolios and Specifications
13.1.3 Pacific Biosciences Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pacific Biosciences Main Business Overview
13.1.5 Pacific Biosciences Latest Developments
13.2 Element Biosciences
13.2.1 Element Biosciences Company Information
13.2.2 Element Biosciences Whole Genome Sequencers Product Portfolios and Specifications
13.2.3 Element Biosciences Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Element Biosciences Main Business Overview
13.2.5 Element Biosciences Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific Whole Genome Sequencers Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Illumina
13.4.1 Illumina Company Information
13.4.2 Illumina Whole Genome Sequencers Product Portfolios and Specifications
13.4.3 Illumina Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Illumina Main Business Overview
13.4.5 Illumina Latest Developments
13.5 Roche
13.5.1 Roche Company Information
13.5.2 Roche Whole Genome Sequencers Product Portfolios and Specifications
13.5.3 Roche Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Roche Main Business Overview
13.5.5 Roche Latest Developments
13.6 GeneMind
13.6.1 GeneMind Company Information
13.6.2 GeneMind Whole Genome Sequencers Product Portfolios and Specifications
13.6.3 GeneMind Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GeneMind Main Business Overview
13.6.5 GeneMind Latest Developments
13.7 Mgi Tech
13.7.1 Mgi Tech Company Information
13.7.2 Mgi Tech Whole Genome Sequencers Product Portfolios and Specifications
13.7.3 Mgi Tech Whole Genome Sequencers Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Mgi Tech Main Business Overview
13.7.5 Mgi Tech Latest Developments
14 Research Findings and Conclusion
*If Applicable.
